: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Flying Publisher

Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM

Vaccines

Free Subscription

Articles published in J Infect Dis
Retrieve available abstracts of 372 articles:
HTML format

Single Articles

May 2020

COWLING BJ, Thompson MG, Ng TWY, Fang VJ, et al
Comparative Reactogenicity of Enhanced Influenza Vaccines in Older Adults.
J Infect Dis. 2020 May 14. pii: 5837136. doi: 10.1093.
PubMed Abstract available

TCHALLA EYI, Bhalla M, Wohlfert EA, Bou Ghanem EN, et al
Neutrophils are required during immunization with the pneumococcal conjugate vaccine for protective antibody responses and host defense against infection.
J Infect Dis. 2020 May 11. pii: 5835638. doi: 10.1093.
PubMed Abstract available

BARTSCH SM, Mitgang EA, Geller G, Cox SN, et al
What if the Influenza Vaccine Did Not Offer Such Variable Protection?
J Infect Dis. 2020 May 9. pii: 5835317. doi: 10.1093.
PubMed Abstract available

YUILL S, Egger S, Smith M, Velentzis L, et al
Has Human Papillomavirus (HPV) Vaccination Prevented Adverse Pregnancy Outcomes? Population-Level Analysis After 8 Years of a National HPV Vaccination Program in Australia.
J Infect Dis. 2020 May 9. pii: 5827184. doi: 10.1093.
PubMed Abstract available

GRAEPEL KW, Kochhar S, Clayton EW, Edwards KE, et al
Balancing Expediency and Scientific Rigor in SARS-CoV-2 Vaccine Development.
J Infect Dis. 2020 May 4. pii: 5828933. doi: 10.1093.
PubMed

SALAMANCA DE LA CUEVA I, Pahud B, Huang LM, Leonardi M, et al
Immunogenicity and safety of porcine circovirus-free human rotavirus vaccine in healthy infants: a phase III, randomized trial.
J Infect Dis. 2020 May 4. pii: 5829005. doi: 10.1093.
PubMed Abstract available

April 2020

CIOFFI A
COVID-19: Is Everything Appropriate to Create an Effective Vaccine?
J Infect Dis. 2020 Apr 29. pii: 5826955. doi: 10.1093.
PubMed

WILLIAMS K, Bastian AR, Feldman RA, Omoruyi E, et al
Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine with an Adenovirus 26 Vector Encoding Pre-Fusion F (Ad26.RSV.preF) in adults 60 years and older.
J Infect Dis. 2020 Apr 22. pii: 5823828. doi: 10.1093.
PubMed Abstract available

SCHWENDINGER M, Thiry G, De Vos B, Leroux-Roels G, et al
A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus.
J Infect Dis. 2020 Apr 21. pii: 5821369. doi: 10.1093.
PubMed Abstract available

MOHN KG, Brokstad KA, Islam S, Oftung F, et al
Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children.
J Infect Dis. 2020;221:1528-1537.
PubMed Abstract available

March 2020

KURTOVIC L, Atre T, Feng G, Wines BD, et al
Multi-functional antibodies are induced by the RTS,S malaria vaccine and associated with protection in a phase I/IIa trial.
J Infect Dis. 2020 Mar 31. pii: 5814271. doi: 10.1093.
PubMed Abstract available

EYAL N, Lipsitch M, Smith PG
Human challenge studies to accelerate coronavirus vaccine licensure.
J Infect Dis. 2020 Mar 31. pii: 5814216. doi: 10.1093.
PubMed Abstract available

SKOWRONSKI DM, Leir S, Sabaiduc S, Chambers C, et al
Influenza vaccine effectiveness by A(H3N2) phylogenetic sub-cluster and prior vaccination history: 2016-17 and 2017-18 epidemics in Canada.
J Infect Dis. 2020 Mar 26. pii: 5811682. doi: 10.1093.
PubMed Abstract available

DE SANJOSE S, Bruni L
Is it now the time to plan for global gender-neutral vaccination?
J Infect Dis. 2020 Mar 11. pii: 5803244. doi: 10.1093.
PubMed

VANSKA S, Luostarinen T, Bausssano I, Apter D, et al
Vaccination with moderate coverage eradicates oncogenic human papillomaviruses if a gender-neutral strategy is applied.
J Infect Dis. 2020 Mar 11. pii: 5803245. doi: 10.1093.
PubMed Abstract available

WILLIAMS FB, Kader A, Colgate ER, Dickson DM, et al
Maternal Secretor Status Affects Oral Rotavirus Vaccine Response in Breastfed Infants in Bangladesh.
J Infect Dis. 2020 Mar 11. pii: 5802696. doi: 10.1093.
PubMed Abstract available

GRIFFITHS P, Hughes B
Choice of Study Populations for Vaccines.
J Infect Dis. 2020;221.
PubMed Abstract available

KRAUSE PR, Roberts J
Scientific and Regulatory Considerations for Efficacy Studies of Cytomegalovirus Vaccines.
J Infect Dis. 2020;221.
PubMed Abstract available

ROARK HK, Jenks JA, Permar SR, Schleiss MR, et al
Animal Models of Congenital Cytomegalovirus Transmission: Implications for Vaccine Development.
J Infect Dis. 2020;221.
PubMed Abstract available

PLOTKIN SA, Wang D, Oualim A, Diamond DJ, et al
The Status of Vaccine Development Against the Human Cytomegalovirus.
J Infect Dis. 2020;221.
PubMed Abstract available

LANZIERI TM, Gastanaduy PA, Gambhir M, Plotkin SA, et al
Review of Mathematical Models of Vaccination for Preventing Congenital Cytomegalovirus Infection.
J Infect Dis. 2020;221.
PubMed Abstract available

February 2020

DAGNEW AF, Klein NP, Herve C, Kalema G, et al
The Adjuvanted Recombinant Zoster Vaccine in Adults Aged >/=65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine.
J Infect Dis. 2020 Feb 27. pii: 5760710. doi: 10.1093.
PubMed Abstract available

IZURIETA HS, Chillarige Y, Kelman J, Wei Y, et al
Relative effectiveness of influenza vaccines among the U.S. elderly, 2018-19.
J Infect Dis. 2020 Feb 26. pii: 5758057. doi: 10.1093.
PubMed Abstract available

BURNETT E, Parashar UD, Tate JE
Global impact of rotavirus vaccination on diarrhea hospitalizations and deaths among children <5 years old: 2006-2019.
J Infect Dis. 2020 Feb 25. pii: 5755890. doi: 10.1093.
PubMed Abstract available

BAKER JM, Tate JE, Leon J, Haber MJ, et al
Post-vaccination serum anti-rotavirus immunoglobulin A as a correlate of protection against rotavirus gastroenteritis across settings.
J Infect Dis. 2020 Feb 15. pii: 5736407. doi: 10.1093.
PubMed Abstract available

MCFARLAND EJ, Karron RA, Muresan P, Cunningham CK, et al
Live-attenuated respiratory syncytial virus vaccine with M2-2 deletion and with SH non-coding region is highly immunogenic in children.
J Infect Dis. 2020 Feb 1. pii: 5719572. doi: 10.1093.
PubMed Abstract available

January 2020

FREYNE B, Messina NL, Donath S, Germano S, et al
Neonatal BCG vaccination reduces interferon gamma responsiveness to heterologous pathogens in infants from a randomised controlled trial.
J Infect Dis. 2020 Jan 28. pii: 5716732. doi: 10.1093.
PubMed Abstract available

HOES J, Pasmans H, Knol MJ, Donken R, et al
Persisting Antibody Response Nine Years after Bivalent HPV Vaccination in A Cohort of Dutch Women: Immune Response and the Relation with Genital HPV Infections.
J Infect Dis. 2020 Jan 9. pii: 5698719. doi: 10.1093.
PubMed Abstract available

December 2019

NILSSON A, Chiodi F
Early antiretroviral therapy may preserve vaccine responses in HIV infected patients by preventing damage to long-lived plasma cells.
J Infect Dis. 2019 Dec 23. pii: 5684907. doi: 10.1093.
PubMed

VADREVU KM, Potula V, Khalatkar V, Mahantshetty NS, et al
Persistence of Immune responses with an Inactivated Japanese Encephalitis single-dose vaccine JENVAC(R) and interchangeability with a live-attenuated vaccine.
J Infect Dis. 2019 Dec 20. pii: 5681576. doi: 10.1093.
PubMed Abstract available

BENNETT A, Pollock L, Jere KC, Pitzer VE, et al
Duration and Density of Fecal Rotavirus Shedding in Vaccinated Malawian Children With Rotavirus Gastroenteritis.
J Infect Dis. 2019 Dec 13. pii: 5676855. doi: 10.1093.
PubMed Abstract available

HENSS L, Yue C, von Rhein C, Tschismarov R, et al
Analysis of humoral immune responses in chikungunya virus (CHIKV) infected patients and individuals vaccinated with a candidate CHIKV vaccine.
J Infect Dis. 2019 Dec 12. pii: 5673548. doi: 10.1093.
PubMed Abstract available

WAGSTAFFE HR, Clutterbuck EA, Bockstal V, Stoop JN, et al
Antibody-Dependent Natural Killer Cell Activation after Ebola Vaccination.
J Infect Dis. 2019 Dec 10. pii: 5672569. doi: 10.1093.
PubMed Abstract available

ENDY TP, Keiser PB, Wang D, Jarman RG, et al
Serologic Response of Two versus Three doses, Intradermal versus Intramuscular Administration of a Licensed Rabies Vaccine for Pre-Exposure Prophylaxis.
J Infect Dis. 2019 Dec 5. pii: 5658469. doi: 10.1093.
PubMed Abstract available

November 2019

MARKOWITZ LE, Naleway AL, Klein NP, Lewis RM, et al
Human Papillomavirus Vaccine Effectiveness Against HPV Infection: Evaluation of One, Two, and Three Doses.
J Infect Dis. 2019 Nov 30. pii: 5648192. doi: 10.1093.
PubMed Abstract available

BONIFACE K, Byars SG, Cowley D, Kirkwood CD, et al
Human Neonatal Rotavirus Vaccine (RV3-BB) Produces Vaccine Take Irrespective of Histo-Blood Group Antigen Status.
J Infect Dis. 2019 Nov 25. pii: 5640309. doi: 10.1093.
PubMed Abstract available

TENG MN, Mejias A, Ramilo O, Peeples ME, et al
Live Attenuated Vaccine with a Stabilized Mutation and Gene Deletion for Prevention of Respiratory Syncytial Virus Disease in Young Children.
J Infect Dis. 2019 Nov 23. pii: 5638037. doi: 10.1093.
PubMed

MCFARLAND EJ, Karron RA, Muresan P, Cunningham CK, et al
Live respiratory syncytial virus attenuated by M2-2 deletion and stabilized temperature sensitivity mutation 1030s is a promising vaccine candidate in children.
J Infect Dis. 2019 Nov 23. pii: 5638036. doi: 10.1093.
PubMed Abstract available

GLASS A, Polhemus M, Wang D, Jarman RG, et al
The Effects of Japanese Encephalitis Vaccine and Accelerated Dosing Scheduling on the Immunogenicity of the Chimeric Yellow Fever Derived Tetravalent Dengue Vaccine (CYD-TDV): A Phase II, Randomized, Open-label, Single Center Trial in Adults Aged 18 t
J Infect Dis. 2019 Nov 22. pii: 5637716. doi: 10.1093.
PubMed Abstract available

LO MK, Spengler JR, Welch SR, Harmon JR, et al
Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters.
J Infect Dis. 2019 Nov 21. pii: 5637464. doi: 10.1093.
PubMed Abstract available

BEALL B, Van Beneden C
Challenges to vaccine development-the diversity of group A streptococcal strains among varied climates and global regions.
J Infect Dis. 2019 Nov 21. pii: 5636891. doi: 10.1093.
PubMed

KEITEL WA, Atmar RL
Corrigendum to : Influenza Vaccines After 7 Decades: Still on the Learning Curve.
J Infect Dis. 2019 Nov 20. pii: 5634378. doi: 10.1093.
PubMed

PUKSURIWONG S, Ahmed MS, Sharma R, Krishnan M, et al
MVA-NP+M1 vaccine activates mucosal M1-specific T cell immunity and tissue-resident memory T cells in human nasopharynx-associated lymphoid tissue.
J Infect Dis. 2019 Nov 19. pii: 5628940. doi: 10.1093.
PubMed Abstract available

SMITH C, Moraka NO, Ibrahim M, Moyo S, et al
HIV Exposure but Not Early CMV Infection is Associated with Increased Hospitalization and Decreased Memory T-cell Responses to Tetanus Vaccine.
J Infect Dis. 2019 Nov 10. pii: 5618838. doi: 10.1093.
PubMed Abstract available

WALKER JL, Zhao H, Dabrera G, Andrews N, et al
Assessment of Effectiveness of Seasonal Influenza Vaccination During Pregnancy in Preventing Influenza Infection in Infants in England, 2013-2014 and 2014-2015.
J Infect Dis. 2019 Nov 9. pii: 5618766. doi: 10.1093.
PubMed Abstract available

ENDY TP, Keiser PB, Cibula D, Abbott M, et al
Effect of Antimalarial Drugs on the Immune Response to Intramuscular Rabies Vaccination Using a Postexposure Prophylaxis Regimen.
J Infect Dis. 2019 Nov 2. pii: 5611063. doi: 10.1093.
PubMed Abstract available

PLOTKIN SA
Is There a Correlate of Protection for Measles Vaccine?
J Infect Dis. 2019 Nov 1. pii: 5610905. doi: 10.1093.
PubMed

October 2019

PATEL JC, Soeters HM, Diallo AO, Bicaba BW, et al
MenAfriNet: A Network Supporting Case-Based Meningitis Surveillance and Vaccine Evaluation in the Meningitis Belt of Africa.
J Infect Dis. 2019;220.
PubMed Abstract available

NOVAK RT, Ronveaux O, Bita AF, Ake HF, et al
Future Directions for Meningitis Surveillance and Vaccine Evaluation in the Meningitis Belt of Sub-Saharan Africa.
J Infect Dis. 2019;220.
PubMed Abstract available

FERNANDEZ K, Lingani C, Aderinola OM, Goumbi K, et al
Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017.
J Infect Dis. 2019;220.
PubMed Abstract available

BWAKA A, Bita A, Lingani C, Fernandez K, et al
Status of the Rollout of the Meningococcal Serogroup A Conjugate Vaccine in African Meningitis Belt Countries in 2018.
J Infect Dis. 2019;220.
PubMed Abstract available

ALDERSON MR, LaForce FM, Sobanjo-Ter Meulen A, Hwang A, et al
Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines.
J Infect Dis. 2019;220.
PubMed Abstract available

SOETERS HM, Kambire D, Sawadogo G, Ouedraogo-Traore R, et al
Impact of 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis, Burkina Faso, 2016-2017.
J Infect Dis. 2019;220.
PubMed Abstract available

ZOMA RL, Walldorf JA, Tarbangdo F, Patel JC, et al
Evaluation of the Impact of Meningococcal Serogroup A Conjugate Vaccine Introduction on Second-Year-of-Life Vaccination Coverage in Burkina Faso.
J Infect Dis. 2019;220.
PubMed Abstract available

SIDIKOU F, Potts CC, Zaneidou M, Mbaeyi S, et al
Epidemiology of Bacterial Meningitis in the Nine Years Since Meningococcal Serogroup A Conjugate Vaccine Introduction, Niger, 2010-2018.
J Infect Dis. 2019;220.
PubMed Abstract available

COHEN C, Nunes MC
Vaccinating Mothers to Protect Their Babies Against Influenza.
J Infect Dis. 2019 Oct 31. pii: 5610713. doi: 10.1093.
PubMed

FLANNERY B, Kondor RJG, Chung JR, Gaglani M, et al
Spread of antigenically drifted influenza A(H3N2) viruses and vaccine effectiveness in the United States during the 2018-2019 season.
J Infect Dis. 2019 Oct 30. pii: 5609441. doi: 10.1093.
PubMed Abstract available

ATMAR RL, Keitel WA
Searching for Improved Flu Vaccines - The Time Is Now.
J Infect Dis. 2019 Oct 30. pii: 5609442. doi: 10.1093.
PubMed

CARBONI F, Angiolini F, Fabbrini M, Brogioni B, et al
GBS type III oligosaccharides containing a minimal protective epitope can be turned into effective vaccines by multivalent presentation.
J Infect Dis. 2019 Oct 23. pii: 5602691. doi: 10.1093.
PubMed Abstract available

MATEO R, Lindesmith LC, Garg SJ, Gottlieb K, et al
Production and Clinical Evaluation of Norwalk GI.1 Virus Lot 001-09NV in Norovirus Vaccine Development.
J Infect Dis. 2019 Oct 20. pii: 5601165. doi: 10.1093.
PubMed Abstract available

BARTLETT S, Eichenberger RM, Nevagi RJ, Ghaffar KA, et al
Lipopeptide-based oral vaccine against hookworm infection.
J Infect Dis. 2019 Oct 17. pii: 5588831. doi: 10.1093.
PubMed Abstract available

LU Y, Chillarige Y, Izurieta HS, Wei Y, et al
Erratum to: Effect of Age on Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries Aged >/=65 Years.
J Infect Dis. 2019 Oct 17. pii: 5588808. doi: 10.1093.
PubMed

KILAPANDAL VENKATRAMAN SM, Sivanandham R, Pandrea I, Apetrei C, et al
BCG Vaccination and Mother-to-Infant Transmission of HIV.
J Infect Dis. 2019 Oct 12. pii: 5586559. doi: 10.1093.
PubMed

WOOD MP, Wood LF, Templeton M, Fisher B, et al
Transient Immune Activation in BCG-Vaccinated Infant Rhesus Macaques Is Not Sufficient to Influence Oral Simian Immunodeficiency Virus Infection.
J Infect Dis. 2019 Oct 12. pii: 5586557. doi: 10.1093.
PubMed Abstract available

KARRON RA, Luongo C, Mateo JS, Wanionek K, et al
Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/DeltaNS2/Delta1313/I1314L in RSV-Seronegative Children.
J Infect Dis. 2019 Oct 12. pii: 5586371. doi: 10.1093.
PubMed Abstract available

FRIES L, Cho I, Krahling V, Fehling SK, et al
A Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein (EBOV GP) Nanoparticle Vaccine with Matrix-M Adjuvant in Healthy Adults.
J Infect Dis. 2019 Oct 11. pii: 5585635. doi: 10.1093.
PubMed Abstract available

BAUSCH DG, Piot P
Ebola Vaccines: Biomedical Advances, Human Rights Challenges.
J Infect Dis. 2019 Oct 11. pii: 5585661. doi: 10.1093.
PubMed

KARUNAKARAN KP, Yu H, Jiang X, Chan QWT, et al
Discordance in the epithelial cell-dendritic cell MHC class II immunoproteome: implications for Chlamydia vaccine development.
J Infect Dis. 2019 Oct 10. pii: 5585005. doi: 10.1093.
PubMed Abstract available

ELLSWORTH GB, Wilkin TJ
Another Call for Widespread Human Papillomavirus Vaccination.
J Infect Dis. 2019 Oct 5. pii: 5581839. doi: 10.1093.
PubMed

BIANCHI FP, Stefanizzi P, De Nitto S, Larocca AMV, et al
Long-term immunogenicity of Measles vaccine: an Italian retrospective cohort study.
J Infect Dis. 2019 Oct 3. pii: 5580522. doi: 10.1093.
PubMed Abstract available

September 2019

COLEMAN KK, Wong CC, Jayakumar J, Nguyen TT, et al
Adenoviral Infections in Singapore: Should New Antiviral Therapies and Vaccines Be Adopted?
J Infect Dis. 2019 Sep 30. pii: 5576003. doi: 10.1093.
PubMed Abstract available

Corrigendum to: Meningococcal Carriage Following a Vaccination Campaign With MenB-4C and MenB-FHbp in Response to a University Serogroup B Meningococcal Disease Outbreak-Oregon, 2015-2016.
J Infect Dis. 2019 Sep 26. pii: 5574032. doi: 10.1093.
PubMed

L'HUILLIER AG, Ferreira VH, Hirzel C, Natori Y, et al
Cell-Mediated Immune Responses after Influenza Vaccination of Solid Organ Transplant Recipients: a Secondary Outcomes Analysis of a Randomized Controlled Trial.
J Infect Dis. 2019 Sep 24. pii: 5573328. doi: 10.1093.
PubMed Abstract available

GERSHON AS, Chung H, Porter J, Campitelli MA, et al
Influenza Vaccine Effectiveness in Preventing Hospitalizations in Older Patients With Chronic Obstructive Pulmonary Disease.
J Infect Dis. 2019 Sep 24. pii: 5573043. doi: 10.1093.
PubMed Abstract available

RAMILO O, Rodriguez-Fernandez R, Peeples ME, Mejias A, et al
Advanced Live Attenuated Vaccines for the Prevention of Respiratory Syncytial Virus Infections in Young Children.
J Infect Dis. 2019 Sep 24. pii: 5573046. doi: 10.1093.
PubMed

KAREKO BW, Booty BL, Nix CD, Lyski ZL, et al
Persistence of Neutralizing Antibody Responses Among Yellow Fever Virus 17D Vaccinees Living in a Nonendemic Setting.
J Infect Dis. 2019 Sep 23. pii: 5572834. doi: 10.1093.
PubMed Abstract available

BARRETT ADT
Yellow Fever Vaccine: The Conundrum of 2 Doses, One Dose, or One-Fifth Dose to Induce and Maintain Protective Immunity.
J Infect Dis. 2019 Sep 23. pii: 5572851. doi: 10.1093.
PubMed

PATEL P, Bush T, Conley L, Unger ER, et al
Prevalence, Incidence, and Clearance of Human Papillomavirus Types Covered by Current Vaccines in Men With Human Immunodeficiency Virus in the SUN Study.
J Infect Dis. 2019 Sep 19. pii: 5571724. doi: 10.1093.
PubMed Abstract available

August 2019

HALPERIN SA, Das R, Onorato MT, Liu K, et al
Immunogenicity, Lot Consistency, and Extended Safety of rVSVDeltaG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults.
J Infect Dis. 2019;220:1127-1135.
PubMed Abstract available

JOHNSON T, Folayan MO
Unintended HIV-1 Transmission to a Sex Partner in a Study of a Therapeutic Vaccine Candidate.
J Infect Dis. 2019;220:1233-1234.
PubMed

KATELARIS AL, Jackson C, Southern J, Gupta RK, et al
Effectiveness of BCG vaccination against Mycobacterium tuberculosis infection in adults: a cross-sectional analysis of a UK-based cohort.
J Infect Dis. 2019 Aug 29. pii: 5556484. doi: 10.1093.
PubMed Abstract available

TIFREA DF, Pal S, de la Maza LM
A recombinant Chlamydia trachomatis MOMP vaccine elicits cross-serogroup protection in mice against vaginal shedding and infertility.
J Infect Dis. 2019 Aug 28. pii: 5555888. doi: 10.1093.
PubMed Abstract available

STACEY HD, Miller MS
Repeated Seasonal Influenza Vaccination-How Much is Too Much of a Good Thing?
J Infect Dis. 2019 Aug 26. pii: 5554481. doi: 10.1093.
PubMed

RICHARDS KA, Shannon I, Treanor JJ, Yang H, et al
Evidence that blunted CD4 T cells responses underlie deficient protective antibody responses to influenza vaccines in repeatedly vaccinated human subjects.
J Infect Dis. 2019 Aug 26. pii: 5554480. doi: 10.1093.
PubMed Abstract available

SCHWARZ TF, McPhee RA, Launay O, Leroux-Roels G, et al
Immunogenicity and safety of 3 formulations of a respiratory syncytial virus candidate vaccine in non-pregnant women: a phase II, randomized trial.
J Infect Dis. 2019 Aug 16. pii: 5550410. doi: 10.1093.
PubMed Abstract available

GODI A, Kemp TJ, Pinto LA, Beddows S, et al
Sensitivity of Human Papillomavirus (HPV) Lineage and Sublineage Variant Pseudoviruses to Neutralization by Nonavalent Vaccine Antibodies.
J Infect Dis. 2019 Aug 15. pii: 5550116. doi: 10.1093.
PubMed Abstract available

SALPINI R, Pietrobattista A, Piermatteo L, Basso MS, et al
Establishment of a seronegative occult infection with an active HBV reservoir enriched of vaccine escape mutations in a vaccinated infant after liver transplant.
J Infect Dis. 2019 Aug 14. pii: 5550108. doi: 10.1093.
PubMed Abstract available

CHOI YH, Perez-Cuevas MB, Kodani M, Zhang X, et al
Feasibility of Hepatitis B Vaccination by Microneedle Patch: Cellular and Humoral Immunity Studies in Rhesus Macaques.
J Infect Dis. 2019 Aug 13. pii: 5549399. doi: 10.1093.
PubMed Abstract available

MUNOZ FM, Swamy GK, Hickman SP, Agrawal S, et al
Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants.
J Infect Dis. 2019 Aug 12. pii: 5546089. doi: 10.1093.
PubMed Abstract available

KURUP D, Fisher CR, Smith TG, Abreu-Mota T, et al
Inactivated Rabies Virus-Based Ebola Vaccine Preserved by Vaporization Is Heat-Stable and Immunogenic Against Ebola and Protects Against Rabies Challenge.
J Infect Dis. 2019 Aug 3. pii: 5543203. doi: 10.1093.
PubMed Abstract available

July 2019

BOPPANA S, Sterrett S, Files J, Qin K, et al
HLA-I associated adaptation dampens the CD8 T-cell response in HIV Ad5-vectored vaccine recipients.
J Infect Dis. 2019 Jul 12. pii: 5532017. doi: 10.1093.
PubMed Abstract available

LALVANI A, Seshadri C
Understanding How BCG Vaccine Protects Against Mycobacterium tuberculosis Infection: Lessons From Household Contact Studies.
J Infect Dis. 2019 Jul 12. pii: 5531579. doi: 10.1093.
PubMed

LU Y, Chillarige Y, Izurieta HS, Wei Y, et al
Effect of age on relative effectiveness of high-dose versus standard-dose influenza vaccines among US Medicare beneficiaries ages 65 years and older.
J Infect Dis. 2019 Jul 9. pii: 5530548. doi: 10.1093.
PubMed Abstract available

CHUA H, Chiu SS, Chan ELY, Feng S, et al
Effectiveness of partial and full influenza vaccination in children aged <9 years in Hong Kong, 2011-2019.
J Infect Dis. 2019 Jul 9. pii: 5530568. doi: 10.1093.
PubMed Abstract available

ROMERO-SAAVEDRA F, Laverde D, Kalfopoulou E, Martini C, et al
Conjugation of different immunogenic enterococcal vaccine target antigens leads to extended strain coverage.
J Infect Dis. 2019 Jul 9. pii: 5530372. doi: 10.1093.
PubMed Abstract available

XING X, Bi S, Fan X, Jin M, et al
Intranasal Immunization with Multi-virulence Factors Promotes Mucosal Clearance of Streptococcus suis across Serotypes and Protects against Meningitis in Mice.
J Infect Dis. 2019 Jul 9. pii: 5530315. doi: 10.1093.
PubMed Abstract available

NG TWY, Perera RAPM, Fang VJ, Yau EM, et al
The effect of influenza vaccination history on changes in hemagglutination inhibition titers following receipt of the 2015/16 influenza vaccine in older adults in Hong Kong.
J Infect Dis. 2019 Jul 6. pii: 5529474. doi: 10.1093.
PubMed Abstract available

MUTSAERTS EAML, Nunes MC, Bhikha S, Ikulinda BT, et al
Immunogenicity and safety of an early measles vaccination schedule at 6 and 12 months of age in HIV-unexposed and HIV-exposed uninfected South African children.
J Infect Dis. 2019 Jul 6. pii: 5529477. doi: 10.1093.
PubMed Abstract available

ADLER SP, Lewis N, Conlon A, Christiansen MP, et al
Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects.
J Infect Dis. 2019;220:411-419.
PubMed Abstract available

SAVARINO SJ, McKenzie R, Tribble DR, Porter CK, et al
Hyperimmune Bovine Colostral Anti-CS17 Antibodies Protect Against Enterotoxigenic Escherichia coli Diarrhea in a Randomized, Doubled-Blind, Placebo-Controlled Human Infection Model.
J Infect Dis. 2019;220:505-513.
PubMed Abstract available

JAGGER BW, Dowd KA, Chen RE, Desai P, et al
Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice.
J Infect Dis. 2019 Jul 1. pii: 5526737. doi: 10.1093.
PubMed Abstract available

June 2019

LARTEY S, Zhou F, Brokstad KA, Mohn KG, et al
Live attenuated influenza vaccine induces tonsillar follicular T helper cell responses that correlate with antibody induction.
J Infect Dis. 2019 Jun 27. pii: 5524503. doi: 10.1093.
PubMed Abstract available

RESIK S, Mach O, Tejeda A, Jeyaseelan V, et al
Immunogenicity of intramuscular fractional dose of inactivated poliovirus vaccine.
J Infect Dis. 2019 Jun 26. pii: 5523769. doi: 10.1093.
PubMed Abstract available

BANDYOPADHYAY AS, Orenstein WA
Evolution of Inactivated Poliovirus Vaccine Use for the Endgame and Beyond.
J Infect Dis. 2019 Jun 26. pii: 5523740. doi: 10.1093.
PubMed

AFKHAMI S, Lai R, D'Agostino MR, Vaseghi-Shanjani M, et al
Single-dose mucosal immunotherapy with chimpanzee adenovirus-based vaccine accelerates TB disease control and limits its rebound following antibiotic cessation.
J Infect Dis. 2019 Jun 13. pii: 5519039. doi: 10.1093.
PubMed Abstract available

ZHONG W, Levine MZ
Stockpiled avian influenza A(H7N9) vaccines induce robust, non-neutralizing functional antibodies against antigenically drifted 5th wave A(H7N9) viruses.
J Infect Dis. 2019 Jun 5. pii: 5511958. doi: 10.1093.
PubMed Abstract available

BOGAARDS JA, van der Weele P, Woestenberg PJ, van Benthem BHB, et al
Bivalent HPV Vaccine Effectiveness Correlates with Phylogenetic Distance from Hpv Vaccine Types 16 And 18.
J Infect Dis. 2019 Jun 4. pii: 5511346. doi: 10.1093.
PubMed Abstract available

REIF DM, Chanock SJ, Edwards KM, Crowe JE, et al
Inappropriate Citation of Vaccine Article.
J Infect Dis. 2019 Jun 3. pii: 5510417. doi: 10.1093.
PubMed

May 2019

GREGIANINI TS, Varella IRS, Fisch P, Martins LG, et al
Dual and Triple Infections With Influenza A and B Viruses: A Case-Control Study in Southern Brazil.
J Infect Dis. 2019 May 29. pii: 5481580. doi: 10.1093.
PubMed Abstract available

MARTINEZ-BAZ I, Navascues A, Casado I, Aguinaga A, et al
Remaining effect of influenza vaccines received in prior seasons.
J Infect Dis. 2019 May 20. pii: 5492310. doi: 10.1093.
PubMed Abstract available

SACCOCCIO FM, Jenks JA, Itell HL, Li SH, et al
Humoral Immune Correlates for Prevention of Postnatal Cytomegalovirus Acquisition.
J Infect Dis. 2019 May 20. pii: 5492326. doi: 10.1093.
PubMed Abstract available

ZAUBERMAN A, Gur D, Levy Y, Aftalion M, et al
Post-exposure administration of a Yersinia pestis live vaccine potentiates second-line antibiotic treatment against pneumonic plague.
J Infect Dis. 2019 May 16. pii: 5490663. doi: 10.1093.
PubMed Abstract available

YAN Y, Wang X, Lou P, Hu Z, et al
A nanoparticle-based HCV vaccine with enhanced potency.
J Infect Dis. 2019 May 10. pii: 5487910. doi: 10.1093.
PubMed Abstract available

LAIDLAW SM, Dustin LB
An HCV vaccine on the fly.
J Infect Dis. 2019 May 10. pii: 5487908. doi: 10.1093.
PubMed

DROPULIC LK, Oestreich MC, Pietz HL, Laing KJ, et al
A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus 2 Vaccine, HSV529, in Adults With or Without HSV Infection.
J Infect Dis. 2019 May 6. pii: 5486075. doi: 10.1093.
PubMed Abstract available

MURRAY AF, Englund JA, Kuypers J, Tielsch JM, et al
Infant pneumococcal carriage during influenza, RSV and hMPV respiratory illness within a maternal influenza immunization trial.
J Infect Dis. 2019 May 6. pii: 5485855. doi: 10.1093.
PubMed Abstract available

ROSSI SL, Comer JE, Wang E, Azar SR, et al
Immunogenicity and Efficacy of a Measles Virus-vectored Chikungunya Vaccine in Nonhuman Primates.
J Infect Dis. 2019 May 3. pii: 5485499. doi: 10.1093.
PubMed Abstract available

AMOAH S, Mishina M, Praphasiri P, Cao W, et al
Standard dose intradermal influenza vaccine elicits similar cellular immune responses when compared to intramuscular vaccine in HIV-infected or uninfected men.
J Infect Dis. 2019 May 2. pii: 5482500. doi: 10.1093.
PubMed Abstract available

April 2019

WOESTENBERG PJ, King AJ, Van Benthem BHB, Leussink S, et al
Bivalent Vaccine Effectiveness Against Anal Human Papillomavirus Positivity Among Female Sexually Transmitted Infection Clinic Visitors in the Netherlands.
J Infect Dis. 2019 Apr 23. pii: 5476422. doi: 10.1093.
PubMed Abstract available

PATRICIA K, Wijmenga-Monsuur AJ, van Houten MA, Veldhuijzen IK, et al
A Third Dose of Measles-Mumps-Rubella Vaccine to Improve Immunity Against Mumps in Young Adults.
J Infect Dis. 2019 Apr 23. pii: 5476427. doi: 10.1093.
PubMed Abstract available

HAYDEN CA, Hung CY, Zhang H, Negron A, et al
Maize-Produced Ag2 as a Subunit Vaccine for Valley Fever.
J Infect Dis. 2019 Apr 23. pii: 5479236. doi: 10.1093.
PubMed Abstract available

KANDASAMY R, Voysey M, Collins S, Berbers G, et al
Persistent circulation of vaccine serotypes and serotype replacement after five years of UK infant immunisation with PCV13.
J Infect Dis. 2019 Apr 20. pii: 5475435. doi: 10.1093.
PubMed Abstract available

PILISHVILI T
Pneumococcal conjugate vaccine effects in the United Kingdom: success of vaccine policy and remaining opportunities for prevention.
J Infect Dis. 2019 Apr 20. pii: 5475438. doi: 10.1093.
PubMed

LEE AD, Clemmons NS, Patel M, Gastanaduy PA, et al
International Importations of Measles Virus into the United States During the Postelimination Era, 2001-2016.
J Infect Dis. 2019;219:1616-1623.
PubMed Abstract available

ATMAR RL, Baehner F, Cramer JP, Lloyd E, et al
Antibody persistence to two Virus-Like Particle norovirus vaccine candidate formulations in healthy adults: one-year follow-up with memory probe vaccination.
J Infect Dis. 2019 Apr 18. pii: 5475178. doi: 10.1093.
PubMed Abstract available

BRINKMAN ID, de Wit J, Smits GP, Ten Hulscher HI, et al
Early measles vaccination during an outbreak in The Netherlands: reduced short and long-term antibody responses in children vaccinated before 12 months of age.
J Infect Dis. 2019 Apr 11. pii: 5441452. doi: 10.1093.
PubMed Abstract available

SUTTER RW, Cochi SL
Inactivated Poliovirus Vaccine Supply Shortage: Is There Light at the End of the Tunnel?
J Infect Dis. 2019 Apr 8. pii: 5432103. doi: 10.1093.
PubMed

HU Y, Wang J, Zeng G, Chu K, et al
Immunogenicity and Safety of a Sabin Strain-Based Inactivated Polio Vaccine: A Phase 3 Clinical Trial.
J Infect Dis. 2019 Apr 8. pii: 5431722. doi: 10.1093.
PubMed Abstract available

MEILLEUR CE, Wardell CM, Mele TS, Dikeakos JD, et al
Bacterial Superantigens Expand and Activate, Rather than Delete or Incapacitate, Preexisting Antigen-Specific Memory CD8+ T Cells.
J Infect Dis. 2019;219:1307-1317.
PubMed Abstract available

CHEN C, van Schaik EJ, Gregory AE, Vigil A, et al
Chemokine Receptor 7 is Essential for Coxiella burnetii Whole-Cell Vaccine Induced Cellular Immunity but Dispensable for Vaccine Mediated Protective Immunity.
J Infect Dis. 2019 Apr 2. pii: 5425888. doi: 10.1093.
PubMed Abstract available

March 2019

HASHEM AM, Algaissi A, Agrawal A, Al-Amri SS, et al
A highly immunogenic, protective and safe adenovirus-based vaccine expressing MERS-CoV S1-CD40L fusion protein in transgenic human DPP4 mouse model.
J Infect Dis. 2019 Mar 26. pii: 5419855. doi: 10.1093.
PubMed Abstract available

SWANSTROM JA, Nivarthi UK, Patel B, Delacruz MJ, et al
Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by NIH Monovalent Dengue Virus Vaccines.
J Infect Dis. 2019 Mar 21. pii: 5416140. doi: 10.1093.
PubMed Abstract available

TEBAS P, Kraynyak KA, Patel A, Maslow JN, et al
Intradermal SynCon(R) Ebola GP DNA Vaccine is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers.
J Infect Dis. 2019 Mar 19. pii: 5395966. doi: 10.1093.
PubMed Abstract available

ZHANG Z, Liang Z, Zeng J, Zhang J, et al
Immunogenicity and safety of an inactivated enterovirus 71 vaccine administered simultaneously with recombinant hepatitis B vaccine and group A meningococcal polysaccharide vaccine: a phase IV, open-label, single-center, randomized, non-inferiority tr
J Infect Dis. 2019 Mar 19. pii: 5395971. doi: 10.1093.
PubMed Abstract available

WANG Y, Esquivel R, Flingai S, Schiller ZA, et al
Anti-OspA DNA-Encoded Monoclonal Antibody Prevents Transmission of Spirochetes in Tick Challenge Providing Sterilizing Immunity in Mice.
J Infect Dis. 2019;219:1146-1150.
PubMed Abstract available

HUYEN DTT, Mach O, Trung NT, Thai PQ, et al
Rapid Disappearance of Poliovirus Type 2 Immunity in Young Children Following Withdrawal of Oral Poliovirus Type 2 Containing Vaccine in Vietnam.
J Infect Dis. 2019 Mar 14. pii: 5380634. doi: 10.1093.
PubMed Abstract available

February 2019

ITURRIZA-GOMARA M, Jere KC, Hungerford D, Bar-Zeev N, et al
Aetiology of diarrhoea among hospitalised children in Blantyre, Malawi following rotavirus vaccine introduction: a case-control study.
J Infect Dis. 2019 Feb 28. pii: 5366554. doi: 10.1093.
PubMed Abstract available

BARANIAK I, Kern F, Holenya P, Griffiths P, et al
Original antigenic sin shapes the immunological repertoire evoked by HCMV gB-MF59 vaccine in seropositive recipients.
J Infect Dis. 2019 Feb 27. pii: 5366424. doi: 10.1093.
PubMed Abstract available

ANYWAINE Z, Whitworth H, Kaleebu P, Praygod G, et al
Randomized clinical trial examining safety and immunogenicity of heterologous prime-boost Ebola vaccines, Ad26.ZEBOV and MVA-BN-Filo: 12-month data from Uganda and Tanzania.
J Infect Dis. 2019 Feb 23. pii: 5364034. doi: 10.1093.
PubMed Abstract available

MUTUA G, Anzala O, Luhn K, Robinson C, et al
Randomized clinical trial examining safety and immunogenicity of heterologous prime-boost Ebola vaccines, Ad26.ZEBOV and MVA-BN-Filo: 12-month data from Nairobi, Kenya.
J Infect Dis. 2019 Feb 23. pii: 5364047. doi: 10.1093.
PubMed Abstract available

CRAWT L, Atkinson E, Tedcastle A, Pegg E, et al
Differences in antigenic structure of inactivated poliovaccines made from Sabin live-attenuated and wild-type poliovirus strains: impact on vaccine potency assays.
J Infect Dis. 2019 Feb 21. pii: 5351027. doi: 10.1093.
PubMed Abstract available

MODLIN J, Chumakov K
Sabin Strain Inactivated Polio Vaccine for the Polio Endgame.
J Infect Dis. 2019 Feb 21. pii: 5351111. doi: 10.1093.
PubMed

SHARMA M, Glasner DR, Watkins H, Puerta-Guardo H, et al
Magnitude and Functionality of the NS1-Specific Antibody Response Elicited by a Live-Attenuated Tetravalent Dengue Vaccine Candidate.
J Infect Dis. 2019 Feb 19. pii: 5345046. doi: 10.1093.
PubMed Abstract available

BUURMAN ET, Timofeyeva Y, Gu J, Kim JH, et al
A novel hexavalent capsular polysaccharide conjugate vaccine (GBS6) for the prevention of neonatal group B streptococcal infections by maternal immunization.
J Infect Dis. 2019 Feb 19. pii: 5336091. doi: 10.1093.
PubMed Abstract available

LELIEVRE JD, Hocqueloux L
Unintended HIV-1 Transmission to a Sex Partner in a Study of a Therapeutic Vaccine Candidate.
J Infect Dis. 2019 Feb 16. pii: 5344456. doi: 10.1093.
PubMed Abstract available

GRAY GC
Adenovirus 4 and 7 vaccine: New Body Armor for Marine Officer Trainees.
J Infect Dis. 2019 Feb 6. pii: 5308337. doi: 10.1093.
PubMed

ZELNER J, Petrie JG, Trangucci R, Martin ET, et al
Effects of sequential influenza A(H1N1)pdm09 vaccination on antibody waning.
J Infect Dis. 2019 Feb 4. pii: 5306487. doi: 10.1093.
PubMed Abstract available

LEVINE MZ, Martin ET, Petrie JG, Lauring AS, et al
Antibodies against egg- and cell-grown influenza A(H3N2) viruses in adults hospitalized during the 2017-2018 season.
J Infect Dis. 2019 Feb 4. pii: 5306481. doi: 10.1093.
PubMed Abstract available

FOLSCHWEILLER N, Behre U, Dionne M, Durando P, et al
Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine.
J Infect Dis. 2019 Feb 3. pii: 5306135. doi: 10.1093.
PubMed Abstract available

January 2019

PAULES CI, Fauci AS
Influenza Vaccines: Good, But We Can Do Better.
J Infect Dis. 2019 Jan 31. pii: 5304932. doi: 10.1093.
PubMed

SAAD-ROY CM, McDermott AB, Grenfell BT
Dynamic perspectives on the search for a universal influenza vaccine.
J Infect Dis. 2019 Jan 31. pii: 5304934. doi: 10.1093.
PubMed Abstract available

CRANK MC, Mascola JR, Graham BS
Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
J Infect Dis. 2019 Jan 31. pii: 5304928. doi: 10.1093.
PubMed

RUDRARAJU R, Mordant F, Subbarao K
How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines.
J Infect Dis. 2019 Jan 31. pii: 5304927. doi: 10.1093.
PubMed

ROSS TM
Universal Influenza Vaccine Approaches Employing Full-Length or Head-only HA Proteins.
J Infect Dis. 2019 Jan 31. pii: 5304925. doi: 10.1093.
PubMed Abstract available

SAELENS X
The Role of M2e in the Development of Universal Influenza Vaccines.
J Infect Dis. 2019 Jan 31. pii: 5304896. doi: 10.1093.
PubMed Abstract available

KANEKIYO M, Ellis D, King NP
New Vaccine Design and Delivery Technologies.
J Infect Dis. 2019 Jan 31. pii: 5304933. doi: 10.1093.
PubMed Abstract available

EICHELBERGER MC, Monto AS
Neuraminidase, the forgotten surface antigen, emerges as an influenza vaccine target for broadened protection.
J Infect Dis. 2019 Jan 31. pii: 5304892. doi: 10.1093.
PubMed Abstract available

KRAMMER F, Palese P
Universal influenza virus vaccines that target the conserved hemagglutinin stalk and conserved sites in the head domain.
J Infect Dis. 2019 Jan 31. pii: 5304926. doi: 10.1093.
PubMed Abstract available

MORENS DM, Taubenberger JK
Making Universal Influenza Vaccines: Lessons from the 1918 Pandemic.
J Infect Dis. 2019 Jan 31. pii: 5304851. doi: 10.1093.
PubMed

ORTIZ JR, Neuzil KM
Influenza Immunization in Low- and Middle-Income Countries: Preparing for Next-Generation Influenza Vaccines.
J Infect Dis. 2019 Jan 31. pii: 5304930. doi: 10.1093.
PubMed Abstract available

SANT AJ
The way forward: Potentiating protective immunity to novel and pandemic influenza through engagement of memory CD4 T cells.
J Infect Dis. 2019 Jan 31. pii: 5304931. doi: 10.1093.
PubMed Abstract available

CROWE JE JR
Antibody Determinants of Influenza Immunity.
J Infect Dis. 2019 Jan 31. pii: 5304924. doi: 10.1093.
PubMed Abstract available

ADLER H, Nikolaou E, Gould K, Hinds J, et al
Pneumococcal colonization in healthy adult research participants in the conjugate vaccine era, United Kingdom, 2010-2017.
J Infect Dis. 2019 Jan 28. pii: 5303784. doi: 10.1093.
PubMed Abstract available

BENNETT A, Pollock L, Jere KC, Pitzer VE, et al
Infrequent Transmission of Monovalent Human Rotavirus Vaccine Virus to Household Contacts of Vaccinated Infants in Malawi.
J Infect Dis. 2019 Jan 24. pii: 5300242. doi: 10.1093.
PubMed Abstract available

GILKEY MB, Margolis MA
Human Papillomavirus Vaccination Coverage Gaps in Young Adolescents.
J Infect Dis. 2019 Jan 17. pii: 5265336. doi: 10.1093.
PubMed

BEDNARCZYK RA, Ellingson MK, Omer SB
Human Papillomavirus Vaccination Before 13 and 15 Years of Age: Analysis of National Immunization Survey Teen Data.
J Infect Dis. 2019 Jan 17. pii: 5265326. doi: 10.1093.
PubMed Abstract available

GAMAGE D, Mach O, Ginige S, Weldon WC, et al
Poliovirus type 2 seroprevalence following full or fractional-dose of inactivated poliovirus vaccine in the period after Sabin type 2 withdrawal in Sri Lanka.
J Infect Dis. 2019 Jan 11. pii: 5288498. doi: 10.1093.
PubMed Abstract available

NEALON J, Taurel AF, Yoksan S, Moureau A, et al
Serological Evidence of Japanese Encephalitis Virus Circulation in Asian Children From Dengue-Endemic Countries.
J Infect Dis. 2019;219:375-381.
PubMed Abstract available

PHIPPS JP, Haas KM
An Adjuvant That Increases Protective Antibody Responses to Polysaccharide Antigens and Enables Recall Responses.
J Infect Dis. 2019;219:323-334.
PubMed Abstract available

MAZUR NI, Horsley NM, Englund JA, Nederend M, et al
Breast Milk Prefusion F Immunoglobulin G as a Correlate of Protection Against Respiratory Syncytial Virus Acute Respiratory Illness.
J Infect Dis. 2019;219:59-67.
PubMed Abstract available

December 2018

HOWARD LM, Goll JB, Jensen TL, Hoek KL, et al
AS03-Adjuvanted H5N1 Avian Influenza Vaccine Modulates Early Innate Immune Signatures In Human Peripheral Blood Mononuclear Cells.
J Infect Dis. 2018 Dec 19. pii: 5253567. doi: 10.1093.
PubMed Abstract available

YANG YYM, Wilson RA, Thomas SRL, Kariuki TM, et al
Micro array-assisted analysis of anti-schistosome glycan antibodies elicited by protective vaccination with irradiated cercariae.
J Infect Dis. 2018 Dec 18. pii: 5250920. doi: 10.1093.
PubMed Abstract available

FLANNERY B, Fry AM
Comparing influenza vaccine types: the path towards improved influenza vaccine strategies.
J Infect Dis. 2018 Dec 18. pii: 5250956. doi: 10.1093.
PubMed

IZURIETA HS, Chillarige Y, Kelman J, Wei Y, et al
Relative effectiveness of cell-cultured and egg-based influenza vaccines among the U.S. elderly, 2017-18.
J Infect Dis. 2018 Dec 18. pii: 5250955. doi: 10.1093.
PubMed Abstract available

BOLAY FK, Grandits G, Lane HC, Kennedy SB, et al
PREVAIL I cluster vaccination study with rVSVG-ZEBOV-GP as part of a public health response in Liberia.
J Infect Dis. 2018 Dec 17. pii: 5250908. doi: 10.1093.
PubMed Abstract available

NG TWY, Cowling BJ, Gao HZ, Thompson MG, et al
Comparative immunogenicity of enhanced seasonal influenza vaccines in older adults: a systematic review and meta-analysis.
J Infect Dis. 2018 Dec 14. pii: 5247419. doi: 10.1093.
PubMed Abstract available

KEITEL WA, Atmar RL
Influenza Vaccines after Seven Decades: Still on the Learning Curve.
J Infect Dis. 2018 Dec 14. pii: 5248489. doi: 10.1093.
PubMed

FERDINANDS JM, Gaglani M, Martin ET, Middleton D, et al
Prevention of influenza hospitalization among adults in the US, 2015-16: Results from the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
J Infect Dis. 2018 Dec 14. pii: 5248488. doi: 10.1093.
PubMed Abstract available

BARTSCH SM, Asti L, Cox S, Durham DP, et al
What is the Value of Different Zika Vaccination Strategies to Prevent and Mitigate Zika Outbreaks.
J Infect Dis. 2018 Dec 13. pii: 5244597. doi: 10.1093.
PubMed Abstract available

KAWAI K, Yawn BP
Risk of Herpes Zoster in Cancer Patients and the Promise of New Vaccines.
J Infect Dis. 2018 Dec 13. pii: 5234725. doi: 10.1093.
PubMed

ZOST SJ, Wu NC, Hensley SE, Wilson IA, et al
Immunodominance and antigenic variation of influenza virus hemagglutinin: implications for design of universal vaccine immunogens.
J Infect Dis. 2018 Dec 9. pii: 5236836. doi: 10.1093.
PubMed

November 2018

SANYAL M, Holmes TH, Maecker H, Albrecht RA, et al
Diminished B-cell response after repeat influenza vaccination.
J Infect Dis. 2018 Nov 28. pii: 5212478. doi: 10.1093.
PubMed Abstract available

POETSCH JH, Dahlke C, Zinser ME, Kasonta R, et al
Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in Humans.
J Infect Dis. 2018 Nov 17. pii: 5187947. doi: 10.1093.
PubMed Abstract available

FINN A
The Hope-Simpson Hypothesis and Its Implications Regarding an Effect of Routine Varicella Vaccination on Herpes Zoster Incidence.
J Infect Dis. 2018 Nov 16. pii: 5184715. doi: 10.1093.
PubMed

GERSHON AA, Brooks D, Stevenson DD, Chin WK, et al
High Constitutive IL-10 Interferes with the Immune Response to Varicella-Zoster Virus (VZV) in Elderly Recipients of Live Attenuated Zoster Vaccine.
J Infect Dis. 2018 Nov 16. pii: 5184646. doi: 10.1093.
PubMed Abstract available

VENKATRAMAN N, Ndiaye BP, Bowyer G, Wade D, et al
Safety and immunogenicity of a heterologous prime-boost Ebola virus vaccine regimen - ChAd3-EBO-Z followed by MVA-EBO-Z in healthy adults in the UK and Senegal.
J Infect Dis. 2018 Nov 8. pii: 5164386. doi: 10.1093.
PubMed Abstract available

October 2018

ROSENBERG T, Philipsen BB, Mehlum CS, Dyrvig AK, et al
Therapeutic use of the HPV vaccine on recurrent respiratory papillomatosis: a systematic review and meta-analysis.
J Infect Dis. 2018 Oct 25. pii: 5144565. doi: 10.1093.
PubMed Abstract available

ARMAH GE, Cortese MM, Dennis FE, Yu Y, et al
Rotavirus Vaccine Take in Infants Is Associated With Secretor Status.
J Infect Dis. 2018 Oct 24. pii: 5144065. doi: 10.1093.
PubMed Abstract available

BEERNINK PT, Ispasanie E, Lewis LA, Ram S, et al
A meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and overexpressed Factor H binding protein elicits gonococcal bactericidal antibodies.
J Infect Dis. 2018 Oct 20. pii: 5139647. doi: 10.1093.
PubMed Abstract available

PATEL A, Reuschel EL, Kraynyak KA, Racine T, et al
Protective Efficacy and Long-Term Immunogenicity in Cynomolgus Macaques by Ebola Virus Glycoprotein Synthetic DNA Vaccines.
J Infect Dis. 2018 Oct 10. pii: 5123708. doi: 10.1093.
PubMed Abstract available

KUDO R, Yamaguchi M, Sekine M, Adachi S, et al
Bivalent Human Papillomavirus Vaccine Effectiveness in a Japanese Population: High Vaccine-Type-Specific Effectiveness and Evidence of Cross-Protection.
J Infect Dis. 2018 Oct 9. pii: 5115492. doi: 10.1093.
PubMed Abstract available

September 2018

PRAHARAJ I, Parker EPK, Giri S, Allen DJ, et al
Influence of non-polio enteroviruses and the bacterial gut microbiota on oral poliovirus vaccine response: a study from south India.
J Infect Dis. 2018 Sep 24. pii: 5106276. doi: 10.1093.
PubMed Abstract available

RAMANI S, Harris V
Going Viral! Unraveling the Impact of Non-polio Enteroviruses on Oral Vaccine Responses.
J Infect Dis. 2018 Sep 24. pii: 5106282. doi: 10.1093.
PubMed

PATEL NP, Vukmanovic-Stejic M, Suarez-Farinas M, Chambers ES, et al
Impact of Zostavax Vaccination on T-Cell Accumulation and Cutaneous Gene Expression in the Skin of Older Humans After Varicella Zoster Virus Antigen-Specific Challenge.
J Infect Dis. 2018;218.
PubMed Abstract available

HARPAZ R, van Hoek AJ
Point-Counterpoint: The Hope-Simpson Hypothesis and Its Implications Regarding an Effect of Routine Varicella Vaccination on Herpes Zoster Incidence.
J Infect Dis. 2018;218.
PubMed Abstract available

GILBERT PB, Luedtke AR
Statistical Learning Methods to Determine Immune Correlates of Herpes Zoster in Vaccine Efficacy Trials.
J Infect Dis. 2018;218.
PubMed Abstract available

WEINBERG A, Kroehl ME, Johnson MJ, Hammes A, et al
Comparative Immune Responses to Licensed Herpes Zoster Vaccines.
J Infect Dis. 2018;218.
PubMed Abstract available

TSENG HF, Sy LS
Use of Real-world Evidence to Evaluate the Effectiveness of Herpes Zoster Vaccine.
J Infect Dis. 2018;218.
PubMed Abstract available

CUNNINGHAM AL, Levin MJ
Herpes Zoster Vaccines.
J Infect Dis. 2018;218.
PubMed Abstract available

BREUER J
Molecular Genetic Insights Into Varicella Zoster Virus (VZV), the vOka Vaccine Strain, and the Pathogenesis of Latency and Reactivation.
J Infect Dis. 2018;218.
PubMed Abstract available

PARKER EPK, Whitfield H, Baskar C, Giri S, et al
FUT2 secretor status is not associated with oral poliovirus vaccine immunogenicity in south Indian infants.
J Infect Dis. 2018 Sep 19. pii: 5102389. doi: 10.1093.
PubMed Abstract available

ARTEMCHUK H, Eriksson T, Poljak M, Surcel HM, et al
Long-Term Antibody Response to Human Papillomavirus Vaccines: up to 12 Years Follow-Up in the Finnish Maternity Cohort.
J Infect Dis. 2018 Sep 18. pii: 5099444. doi: 10.1093.
PubMed Abstract available

SCHALTZ-BUCHHOLZER F, Biering-Sorensen S, Lund N, Monteiro I, et al
Early Bacille Calmette-Guerin vaccination, hospitalizations and hospital deaths: Analysis of a secondary outcome in three randomized trials from Guinea-Bissau.
J Infect Dis. 2018 Sep 18. pii: 5099442. doi: 10.1093.
PubMed Abstract available

CIGLENECKI I, Azman AS, Jamet C, Serafini M, et al
Progress and Challenges in Using Oral Cholera Vaccines to Control Outbreaks: The Medecins Sans Frontieres Experience.
J Infect Dis. 2018 Sep 14. pii: 5098246. doi: 10.1093.
PubMed Abstract available

ATMAR RL, Cramer JP, Baehner F, Han C, et al
An exploratory study of the salivary IgA responses to one dose of a Norovirus VLP candidate vaccine in healthy adults.
J Infect Dis. 2018 Sep 10. pii: 5094041. doi: 10.1093.
PubMed Abstract available

MARSHALL HS, Clarke M, Heath C, Quinn H, et al
Severe and complicated varicella and associated genotypes 10 years after introduction of a one dose varicella vaccine program.
J Infect Dis. 2018 Sep 3. pii: 5089719. doi: 10.1093.
PubMed Abstract available

HARRIS JB
Cholera: Immunity and Prospects in Vaccine Development.
J Infect Dis. 2018 Sep 1. pii: 5089248. doi: 10.1093.
PubMed Abstract available

August 2018

WEINBERG A, Popmihajlov Z, Schmader KE, Johnson MJ, et al
Persistence of varicella-zoster virus cell-mediated immunity after the administration of a second dose of live herpes zoster vaccine.
J Infect Dis. 2018 Aug 28. pii: 5084879. doi: 10.1093.
PubMed Abstract available

SCHWETZ TA, Fauci AS
The Extended Impact of Human Immunodeficiency Virus/AIDS Research.
J Infect Dis. 2018 Aug 28. pii: 5063659. doi: 10.1093.
PubMed Abstract available

LI Z, Chang P, Xu J, Tan C, et al
A Streptococcus suis live vaccine suppresses streptococcal toxic shock-like syndrome and provides sequence type independent protectionTITLE.
J Infect Dis. 2018 Aug 27. pii: 5081797. doi: 10.1093.
PubMed Abstract available

CAGIGI A, Ploquin A, Niezold T, Zhou Y, et al
Vaccine-Mediated Induction of an Ebolavirus Cross-Species Antibody Binding to Conserved Epitopes on the Glycoprotein Heptad Repeat 2/Membrane-Proximal External Junction.
J Infect Dis. 2018 Aug 22. pii: 5078072. doi: 10.1093.
PubMed Abstract available

CHANOUZAS D, Sagmeister M, Faustini S, Nightingale P, et al
Subclinical reactivation of cytomegalovirus drives CD4+CD28null T-cell expansion and impaired immune response to pneumococcal vaccination in ANCA-associated vasculitis.
J Infect Dis. 2018 Aug 9. pii: 5068409. doi: 10.1093.
PubMed Abstract available

VELAZQUEZ-MOCTEZUMA R, Galli A, Law M, Bukh J, et al
Hepatitis C virus escape studies for human monoclonal antibody AR4A reveal isolate-specific resistance and a high barrier to resistance.
J Infect Dis. 2018 Aug 9. pii: 5068268. doi: 10.1093.
PubMed Abstract available

WATANABE S, Tan NWW, Chan KWK, Vasudevan SG, et al
Dengue and Zika Virus Serological Cross-reactivity and their Impact on Pathogenesis in Mice.
J Infect Dis. 2018 Aug 2. pii: 5064258. doi: 10.1093.
PubMed Abstract available

LIANG Y, Che Y, Yang B, Zhan F, et al
Immunogenicity and safety of an F-genotype attenuated mumps vaccine in healthy 8- to 24-month-old children.
J Infect Dis. 2018 Aug 1. pii: 5063175. doi: 10.1093.
PubMed Abstract available

LAZCANO-PONCE E, Torres-Ibarra L, Cruz-Valdez A, Salmeron J, et al
Persistence of immunity when using different HPV vaccination schedules and booster dose effects at 5 years post-primary vaccination.
J Infect Dis. 2018 Aug 1. pii: 5063117. doi: 10.1093.
PubMed Abstract available

July 2018

SUSCHAK JJ, Bagley K, Shoemaker CJ, Six C, et al
The Genetic Adjuvants Interleukin-12 and Granulocyte-Macrophage Colony Stimulating Factor Enhance the Immunogenicity of an Ebola Virus Deoxyribonucleic Acid Vaccine in Mice.
J Infect Dis. 2018 Jul 19. pii: 5056373. doi: 10.1093.
PubMed Abstract available

HUANG QS, Bandaranayake D, Wood T, Newbern EC, et al
Risk factors and attack rates of seasonal influenza infection: results of the SHIVERS seroepidemiologic cohort study.
J Infect Dis. 2018 Jul 17. pii: 5054657. doi: 10.1093.
PubMed Abstract available

FEIRING B, Laake I, Christiansen IK, Hansen M, et al
Substantial decline in prevalence of vaccine-type and non-vaccine type HPV in vaccinated and unvaccinated girls 5 years after implementing HPV vaccine in Norway.
J Infect Dis. 2018 Jul 16. pii: 5054086. doi: 10.1093.
PubMed Abstract available

POPPER SJ, Strouts FR, Lindow JC, Cheng HK, et al
Early transcriptional responses after dengue vaccination mirror the response to natural infection and predict neutralizing antibody titers.
J Infect Dis. 2018 Jul 14. pii: 5053882. doi: 10.1093.
PubMed Abstract available

COWLING BJ, Sullivan SG
The value of neuraminidase inhibition antibody titers in influenza seroepidemiology.
J Infect Dis. 2018 Jul 14. pii: 5053899. doi: 10.1093.
PubMed

CAGIGI A, Misasi J, Ploquin A, Stanley DA, et al
Vaccine Generation of Protective Ebola Antibodies and Identification of Conserved B-Cell Signatures.
J Infect Dis. 2018 Jul 12. pii: 5052389. doi: 10.1093.
PubMed Abstract available

VAN WAGONER N, Fife K, Leone PA, Bernstein DI, et al
Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital HSV-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-controlled Trial.
J Infect Dis. 2018 Jul 6. pii: 5049813. doi: 10.1093.
PubMed Abstract available

ANGUIANO-ZARATE SS, Matchett WE, Nehete P, Sastry KJ, et al
A Replicating Single-cycle Adenovirus Vaccine against Ebola Virus.
J Infect Dis. 2018 Jul 6. pii: 5049708. doi: 10.1093.
PubMed Abstract available

HOLBROOK MR
Will a single-cycle Adenovirus vaccine be effective against Ebola virus?
J Infect Dis. 2018 Jul 6. pii: 5049709. doi: 10.1093.
PubMed

YOUSAFZAI MT
Role of fractional dose intradermal inactivated poliovirus vaccine in halting polio transmission: finding the missing piece for global polio eradication.
J Infect Dis. 2018 Jul 5. pii: 5049362. doi: 10.1093.
PubMed

GAMAGE D, Mach O, Palihawadana P, Zhang Y, et al
Boosting of mucosal immunity after fractional-dose inactivated poliovirus vaccine.
J Infect Dis. 2018 Jul 5. pii: 5049361. doi: 10.1093.
PubMed Abstract available

June 2018

WARFIELD KL, Howell KA, Vu H, Geisbert J, et al
Role of Antibodies in Protection Against Ebola Virus in Nonhuman Primates Immunized With Three Vaccine Platforms.
J Infect Dis. 2018 Jun 25. pii: 5043486. doi: 10.1093.
PubMed Abstract available

FUENTES S, Ravichandran S, Khurana S
Antibody Repertoire of Human Polyclonal Antibodies Against Ebola Virus Glycoprotein Generated After Deoxyribonucleic Acid and Protein Vaccination of Transchromosomal Bovines.
J Infect Dis. 2018 Jun 25. pii: 5043463. doi: 10.1093.
PubMed Abstract available

LIU F, Tzeng WP, Horner L, Kamal RP, et al
Both Immune Priming and Egg-adaptation in the Vaccine Influence Antibody Responses to Circulating A(H1N1)pdm09 Viruses Following Influenza Vaccination in Adults.
J Infect Dis. 2018 Jun 21. pii: 5042019. doi: 10.1093.
PubMed Abstract available

SOUCY AM, Hurteau GJ, Metzger DW
Live vaccination generates both disease tolerance and host resistance during chronic pulmonary infection with highly virulent F. tularensis SchuS4.
J Infect Dis. 2018 Jun 20. pii: 5040507. doi: 10.1093.
PubMed Abstract available

MESHER D, Panwar K, Thomas SL, Edmundson C, et al
The Impact of the National HPV Vaccination Program in England Using the Bivalent HPV Vaccine: Surveillance of Type-Specific HPV in Young Females, 2010-2016.
J Infect Dis. 2018 Jun 18. pii: 5025126. doi: 10.1093.
PubMed Abstract available

LIU Y, Ye L, Lin F, Gomaa Y, et al
Intradermal Vaccination With Adjuvanted Ebola Virus Soluble Glycoprotein Subunit Vaccine by Microneedle Patches Protects Mice Against Lethal Ebola Virus Challenge.
J Infect Dis. 2018 Jun 8. pii: 5034941. doi: 10.1093.
PubMed Abstract available

ALI A, Ng HL, Blankson JN, Burton DR, et al
Highly Attenuated Infection with a Vpr-Deleted Molecular Clone of HIV-1.
J Infect Dis. 2018 Jun 7. pii: 5033983. doi: 10.1093.
PubMed Abstract available

May 2018

SWANSTROM JA, Henein S, Plante JA, Yount BL, et al
Analyzing the Human Serum Antibody Responses to a Live Attenuated Tetravalent Dengue Vaccine Candidate.
J Infect Dis. 2018;217:1932-1941.
PubMed Abstract available

KAINULAINEN MH, Spengler JR, Welch SR, Coleman-McCray JD, et al
Use of a Scalable Replicon-Particle Vaccine to Protect Against Lethal Lassa Virus Infection in the Guinea Pig Model.
J Infect Dis. 2018;217:1957-1966.
PubMed Abstract available

PERCIANI CT, Sekhon M, Hundal S, Farah B, et al
Live-attenuated Zoster Vaccine Boosts VZV-specific Humoral Responses Systemically and at the Cervico-vaginal Mucosa of Kenyan VZV-seropositive Women.
J Infect Dis. 2018 May 25. pii: 5003463. doi: 10.1093.
PubMed Abstract available

CHAKRABORTY S, Randall A, Vickers TJ, Molina D, et al
Human experimental challenge with enterotoxigenic Escherichia coli elicits immune responses to canonical and novel antigens relevant to vaccine development.
J Infect Dis. 2018 May 24. pii: 5003007. doi: 10.1093.
PubMed Abstract available

PAMNANI SJ, Sudenga SL, Rollison DE, Ingles DJ, et al
Recurrence of Genital Infections with Nine HPV Vaccine Types (6, 11, 16, 18, 31, 33, 45, 52, and 58) among Men in the HPV Infection in Men (HIM) Study.
J Infect Dis. 2018 May 24. pii: 5002064. doi: 10.1093.
PubMed Abstract available

BERNSTEIN DI
Rotavirus Vaccines: Mind Your Ps and Gs.
J Infect Dis. 2018 May 22. pii: 5001445. doi: 10.1093.
PubMed

ROCZO-FARKAS S, Kirkwood CD, Cowley D, Barnes GL, et al
The Impact of Rotavirus Vaccines on Genotype Diversity: A Comprehensive Analysis of 2 Decades of Australian Surveillance Data.
J Infect Dis. 2018 May 22. pii: 5001444. doi: 10.1093.
PubMed Abstract available

KABINEH AK, Carr W, Motevalli M, Legardy-Williams J, et al
Operationalizing International Regulatory Standards in a Limited-Resource Setting During an Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE) Experience.
J Infect Dis. 2018;217.
PubMed Abstract available

CARTER RJ, Senesi RGB, Dawson P, Gassama I, et al
Participant Retention in a Randomized Clinical Trial in an Outbreak Setting: Lessons From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).
J Infect Dis. 2018;217.
PubMed Abstract available

CONTEH MA, Goldstein ST, Wurie HR, Gidudu J, et al
Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola.
J Infect Dis. 2018;217.
PubMed Abstract available

JARRETT OD, Seward JF, Fombah AE, Lindblad R, et al
Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola.
J Infect Dis. 2018;217.
PubMed Abstract available

SAMAI M, Seward JF, Goldstein ST, Mahon BE, et al
The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSVG-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak.
J Infect Dis. 2018;217.
PubMed Abstract available

SCHUCHAT A, Seward JF, Goldstein ST, Mahon BE, et al
Comment: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).
J Infect Dis. 2018;217.
PubMed

CARTER RJ, Idriss A, Widdowson MA, Samai M, et al
Implementing a Multisite Clinical Trial in the Midst of an Ebola Outbreak: Lessons Learned From the Sierra Leone Trial to Introduce a Vaccine Against Ebola.
J Infect Dis. 2018;217.
PubMed Abstract available

FOMBAH AE, Goldstein ST, Jarrett OD, Jalloh MI, et al
Health Conditions in an Adult Population in Sierra Leone: Data Reported From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).
J Infect Dis. 2018;217.
PubMed Abstract available

EDEM-HOTAH J, McDonald W, Abu PM, Luman ET, et al
Utilizing Nurses to Staff an Ebola Vaccine Clinical Trial in Sierra Leone during the Ebola Outbreak.
J Infect Dis. 2018;217.
PubMed Abstract available

JUSU MO, Glauser G, Seward JF, Bawoh M, et al
Rapid Establishment of a Cold Chain Capacity of -60 degrees C or Colder for the STRIVE Ebola Vaccine Trial During the Ebola Outbreak in Sierra Leone.
J Infect Dis. 2018;217.
PubMed Abstract available

GARLAND SM, Pitisuttithum P, Ngan HYS, Cho CH, et al
Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants From Asian Countries.
J Infect Dis. 2018 May 15. pii: 4996119. doi: 10.1093.
PubMed Abstract available

FARMAKI PF, Chini MC, Mangafas NM, Tzanoudaki MT, et al
Immunogenicity and Immunological Memory Induced by the 13-Valent Pneumococcal Conjugate Followed by the 23-Valent Polysaccharide Vaccine in HIV-Infected Adults.
J Infect Dis. 2018 May 2. pii: 4990938. doi: 10.1093.
PubMed Abstract available

April 2018

CARROLL TD, Jegaskanda S, Matzinger SR, Fritts L, et al
A lipid/DNA adjuvant-inactivated influenza virus vaccine protects rhesus macaques from uncontrolled virus replication after heterosubtypic influenza A virus challenge.
J Infect Dis. 2018 Apr 26. pii: 4986227. doi: 10.1093.
PubMed Abstract available

JOYCE JC, Carroll TD, Collins ML, Chen MH, et al
A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques.
J Infect Dis. 2018 Apr 26. pii: 4986788. doi: 10.1093.
PubMed Abstract available

MAY S, Mandal S, Keel P, Haywood B, et al
Hepatitis B virus immunisation and neonatal acquisition of persistent infection in England and Wales.
J Infect Dis. 2018 Apr 24. pii: 4982944. doi: 10.1093.
PubMed Abstract available

AMLABU E, Mensah-Brown H, Nyarko PB, Akuh OA, et al
Functional Characterization of Plasmodium falciparum Surface Related Antigen (PfSRA) as a Potential Blood-Stage Vaccine Target.
J Infect Dis. 2018 Apr 18. pii: 4975396. doi: 10.1093.
PubMed Abstract available

DE VRIES RD, Altenburg AF, Nieuwkoop NJ, de Bruin E, et al
Induction of Cross-Clade Antibody and T-Cell Responses by an MVA-Based Influenza H5N1 Vaccine in a Randomized Phase I/IIa Clinical Trial.
J Infect Dis. 2018 Apr 18. pii: 4975691. doi: 10.1093.
PubMed Abstract available

LIN KY, Hsieh SM, Sheng WH, Lo YC, et al
Comparable serologic responses to 2 different combinations of inactivated HAV vaccines in HIV-positive patients during the acute hepatitis A outbreak in Taiwan.
J Infect Dis. 2018 Apr 16. pii: 4972613. doi: 10.1093.
PubMed Abstract available

BADEN LR, Walsh SR, Seaman MS, Cohen YZ, et al
First-in-Human Randomized Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.
J Infect Dis. 2018 Apr 13. pii: 4969772. doi: 10.1093.
PubMed Abstract available

HAIDARA FC, Tapia MD, Sow SO, Doumbia M, et al
Evaluation of a Booster Dose of Pentavalent Rotavirus Vaccine Co-Administered with Measles, Yellow Fever and Meningitis A Vaccines in 9-month-old Malian Infants.
J Infect Dis. 2018 Apr 12. pii: 4969416. doi: 10.1093.
PubMed Abstract available

ZIMMERMANN P, Finn A, Curtis N
Does BCG Vaccination Protect Against Non-Tuberculous Mycobacterial Infection? A Systematic Review and Meta-Analysis.
J Infect Dis. 2018 Apr 7. pii: 4964710. doi: 10.1093.
PubMed Abstract available

March 2018

LANGLEY JM, MacDonald LD, Weir GM, MacKinnon-Cameron D, et al
A Respiratory Syncytial Virus vaccine based on the Small Hydrophobic protein ectodomain presented with a novel lipid-based formulation is highly immunogenic and safe in adults: a first-in-humans study.
J Infect Dis. 2018 Mar 30. pii: 4956800. doi: 10.1093.
PubMed Abstract available

MANNING JE, Morens DM, Kamhawi S, Valenzuela JG, et al
Mosquito saliva: the hope for a universal arbovirus vaccine?
J Infect Dis. 2018 Mar 29. pii: 4956143. doi: 10.1093.
PubMed Abstract available

GUO Q, Chan JF, Poon VK, Wu S, et al
Immunization with a Novel Human type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models.
J Infect Dis. 2018 Mar 29. pii: 4956202. doi: 10.1093.
PubMed Abstract available

FENG G, Boyle MJ, Cross N, Chan JA, et al
Human immunization with a polymorphic malaria vaccine candidate induced antibodies to conserved epitopes that promote functional antibodies to multiple parasite strains.
J Infect Dis. 2018 Mar 23. pii: 4952401. doi: 10.1093.
PubMed Abstract available

PATEL EU, Grabowski MK, Eisenberg AL, Packman ZR, et al
Increases in Human Papillomavirus Vaccination Among Adolescent and Young Adult Males in the United States, 2011-2016.
J Infect Dis. 2018 Mar 23. pii: 4951824. doi: 10.1093.
PubMed Abstract available

ANGRISANO F, Blagborough AM
Understanding human-derived antibodies generated by polymorphic malaria vaccine against merozoite surface protein 2.
J Infect Dis. 2018 Mar 23. pii: 4952403. doi: 10.1093.
PubMed

SCHLEISS MR
Searching for a Serological Correlate of Protection for a CMV Vaccine.
J Infect Dis. 2018 Mar 8. pii: 4924674. doi: 10.1093.
PubMed

BARANIAK I, Kropff B, McLean GR, Pichon S, et al
Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine with MF59: Anti-AD2 Levels Correlate with Protection from Viremia.
J Infect Dis. 2018 Mar 8. pii: 4924673. doi: 10.1093.
PubMed Abstract available

ROGAWSKI ET, Platts-Mills JA, Colgate ER, Haque R, et al
Quantifying the Impact of Natural Immunity on Rotavirus Vaccine Efficacy Estimates: A Clinical Trial in Dhaka, Bangladesh (PROVIDE) and a Simulation Study.
J Infect Dis. 2018;217:861-868.
PubMed Abstract available

BUCHHOLZ UJ, Cunningham CK, Muresan P, Gnanashanmugam D, et al
Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children.
J Infect Dis. 2018 Mar 2. pii: 4917539. doi: 10.1093.
PubMed Abstract available

POLACK FP
Crafting Live-Attenuated Vaccines Against Respiratory Syncytial Virus.
J Infect Dis. 2018 Mar 2. pii: 4917537. doi: 10.1093.
PubMed

MCFARLAND EJ, Karron RA, Muresan P, Cunningham CK, et al
Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children.
J Infect Dis. 2018 Mar 2. pii: 4917538. doi: 10.1093.
PubMed Abstract available

February 2018

ERBELDING EJ, Post D, Stemmy E, Roberts PC, et al
A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.
J Infect Dis. 2018 Feb 28. pii: 4904047. doi: 10.1093.
PubMed Abstract available

CUNNINGHAM AL, Heineman TC, Lal H, Godeaux O, et al
Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged >/=50 Years.
J Infect Dis. 2018 Feb 26. pii: 4911103. doi: 10.1093.
PubMed Abstract available

YOUNG-XU Y, Van Aalst R, Mahmud SM, Rothman KJ, et al
Relative Vaccine Effectiveness of High-Dose versus Standard-Dose Influenza Vaccines among Veterans Health Administration Patients.
J Infect Dis. 2018 Feb 14. pii: 4858294. doi: 10.1093.
PubMed Abstract available

KOJIC EM, Conley L, Bush T, Cu-Uvin S, et al
Prevalence and Incidence of Anal and Cervical High-Risk Human Papillomavirus (HPV) Types covered by Current HPV Vaccines among HIV-Infected Women in the Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (The SUN Study
J Infect Dis. 2018 Feb 14. pii: 4857222. doi: 10.1093.
PubMed Abstract available

BIERING-SORENSEN S, Jensen KJ, Monterio I, Ravn H, et al
Rapid Protective Effects of Early BCG on Neonatal Mortality Among Low Birth Weight Boys: Observations From Randomized Trials.
J Infect Dis. 2018;217:759-766.
PubMed Abstract available

LO NC, Gupta R, Stanaway JD, Garrett DO, et al
Comparison of Strategies and Incidence Thresholds for Vi Conjugate Vaccines Against Typhoid Fever: A Cost-effectiveness Modeling Study.
J Infect Dis. 2018 Feb 12. pii: 4851280. doi: 10.1093.
PubMed Abstract available

ZENKLUSEN I, Jongo S, Abdulla S, Ramadhani K, et al
Immunization of malaria pre-exposed volunteers with PfSPZ Vaccine elicits long-lived IgM invasion-inhibitory and complement-fixing antibodies.
J Infect Dis. 2018 Feb 8. pii: 4845622. doi: 10.1093.
PubMed Abstract available

MACHALEK DA, Garland SM, Brotherton JML, Bateson D, et al
Very low prevalence of vaccine human papillomavirus (HPV) types among 18 to 35 year old Australian women, nine years following implementation of vaccination.
J Infect Dis. 2018 Feb 7. pii: 4841780. doi: 10.1093.
PubMed Abstract available

FREYNE B, Donath S, Germano S, Gardiner K, et al
Neonatal BCG vaccination influences cytokine responses to Toll-like receptor ligands and heterologous antigens.
J Infect Dis. 2018 Feb 3. pii: 4837044. doi: 10.1093.
PubMed Abstract available

DONKEN R, King AJ, Bogaards JA, Woestenberg PJ, et al
High effectiveness of the bivalent HPV vaccine up to six years post-vaccination against incident and persistent HPV infections in young Dutch females.
J Infect Dis. 2018 Feb 2. pii: 4835373. doi: 10.1093.
PubMed Abstract available

LEVIN MJ, Cai GY, Lee KS, Rouphael NG, et al
Varicella-Zoster Virus DNA in Blood After Administration of Herpes Zoster Vaccine.
J Infect Dis. 2018 Feb 2. pii: 4835758. doi: 10.1093.
PubMed Abstract available

POLLOCK KGJ
Sustained cross-protection of the bivalent HPV vaccine.
J Infect Dis. 2018 Feb 2. pii: 4835375. doi: 10.1093.
PubMed

BERAN J, Lickliter JD, Schwarz TF, Johnson C, et al
Safety and immunogenicity of 3 formulations of an investigational respiratory syncytial virus vaccine in non-pregnant women: results from two phase II trials.
J Infect Dis. 2018 Feb 1. pii: 4833521. doi: 10.1093.
PubMed Abstract available

SHANG L, Smith AJ, Duan L, Perkey KE, et al
Vaccine-associated maintenance of epithelial integrity correlated with protection against virus entry.
J Infect Dis. 2018 Feb 1. pii: 4833184. doi: 10.1093.
PubMed Abstract available

January 2018

PIPKINS HR, Bradshaw JL, Keller LE, McDaniel LS, et al
Virulence of an Encapsulated Streptococcus pneumoniae is Increased Upon Expression of Pneumococcal Surface Protein K.
J Infect Dis. 2018 Jan 31. pii: 4830491. doi: 10.1093.
PubMed Abstract available

LEE B, Dickson DM, deCamp AC, Colgate ER, et al
Histoblood Group Antigen Phenotype Determines Susceptibility to Genotype-specific Rotavirus Infections and Impacts Measures of Rotavirus Vaccine Efficacy.
J Infect Dis. 2018 Jan 30. pii: 4829672. doi: 10.1093.
PubMed Abstract available

MALHOTRA I, LaBeaud AD, Morris N, McKibben M, et al
Cord Blood Anti-Parasite IL-10 as Risk Marker for Compromised Vaccine Immunogenicity in Early Childhood.
J Infect Dis. 2018 Jan 30. pii: 4829506. doi: 10.1093.
PubMed Abstract available

JUNG J, Ko SJ, Oh HS, Moon SM, et al
Protective effectiveness of inactivated hantavirus vaccine against hemorrhagic fever with renal syndrome.
J Infect Dis. 2018 Jan 24. pii: 4823438. doi: 10.1093.
PubMed Abstract available

CHENG AC, Subbarao K
Epidemiological Data on the Effectiveness of Influenza Vaccine-Another Piece of the Puzzle.
J Infect Dis. 2018 Jan 18. pii: 4816917. doi: 10.1093.
PubMed

FLANNERY B, Smith C, Garten RJ, Levine MZ, et al
Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States.
J Infect Dis. 2018 Jan 18. pii: 4816916. doi: 10.1093.
PubMed Abstract available

WILSON P, Parr JB, Jhaveri R, Meshnick SR, et al
Call to action: Prevention of mother-to-child transmission of hepatitis B in Africa.
J Infect Dis. 2018 Jan 17. pii: 4812591. doi: 10.1093.
PubMed Abstract available

CHIU SS, Kwan MYW, Feng S, Wong JSC, et al
Influenza vaccine effectiveness against influenza A(H3N2) hospitalizations in children in Hong Kong in a prolonged season, 2016/17.
J Infect Dis. 2018 Jan 16. pii: 4810661. doi: 10.1093.
PubMed Abstract available

KAPIL P, Papin JF, Wolf RF, Zimmerman LI, et al
Maternal Vaccination with a Mono-component Pertussis Toxoid Vaccine is Sufficient to Protect Infants in a Baboon Model of Whooping Cough.
J Infect Dis. 2018 Jan 15. pii: 4808590. doi: 10.1093.
PubMed Abstract available

CAPEDING MR, Alberto ER, Bouckenooghe A, Laot TM, et al
Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV-Primed Children in the Philippines.
J Infect Dis. 2018 Jan 9. pii: 4794746. doi: 10.1093.
PubMed Abstract available

PRINGLE KD, Burke RM, Steiner CA, Parashar UD, et al
Trends in Rate of Seizure-Associated Hospitalizations Among Children <5 Years Old Before and After Rotavirus Vaccine Introduction in the United Sates, 2000-2013.
J Infect Dis. 2018 Jan 9. pii: 4796788. doi: 10.1093.
PubMed Abstract available

FONG Y, Shen X, Ashley VC, Deal A, et al
Vaccine-induced antibody responses modify the association between T-cell immune responses and HIV-1 infection risk in HVTN 505.
J Infect Dis. 2018 Jan 8. pii: 4792964. doi: 10.1093.
PubMed Abstract available

BRICKLEY EB, Strauch CB, Wieland-Alter WF, Connor RI, et al
Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine.
J Infect Dis. 2018 Jan 3. pii: 4788281. doi: 10.1093.
PubMed Abstract available

SUTTER RW
Unraveling the Mucosal Immunity of Inactivated Poliovirus Vaccine.
J Infect Dis. 2018 Jan 3. pii: 4788256. doi: 10.1093.
PubMed

GIRI S, Kumar N, Dhanapal P, Venkatesan J, et al
The quantity of vaccine poliovirus shedding determines the titer of the serum neutralizing antibody response in Indian children vaccinated with oral vaccine.
J Infect Dis. 2018 Jan 2. pii: 4782493. doi: 10.1093.
PubMed Abstract available

December 2017

RAMILO O, Rodriguez-Fernandez R, Mejias A
One Step Forward in the Road Toward a Universal Influenza Vaccine.
J Infect Dis. 2017;217:1-2.
PubMed

MAJUMDAR M, Klapsa D, Wilton T, Akello J, et al
Isolation of vaccine-like poliovirus strains in sewage samples from the UK.
J Infect Dis. 2017 Dec 22. pii: 4772162. doi: 10.1093.
PubMed Abstract available

MEYER M, Huang E, Yuzhakov O, Ramanathan P, et al
Modified mRNA-Based Vaccines Elicit Robust Immune Responses and Protect Guinea Pigs From Ebola Virus Disease.
J Infect Dis. 2017 Dec 21. pii: 4770157. doi: 10.1093.
PubMed Abstract available

DURBIN AP, Whitehead SS
Zika Vaccines: Role for Controlled Human Infection.
J Infect Dis. 2017;216.
PubMed Abstract available

MORABITO KM, Graham BS
Zika Virus Vaccine Development.
J Infect Dis. 2017;216.
PubMed Abstract available

GRUBER MF, Farizo KM, Pratt RD, Fink DL, et al
Clinical Development Strategies and Considerations for Zika Vaccine Licensure.
J Infect Dis. 2017;216.
PubMed Abstract available

OSUNA CE, Whitney JB
Nonhuman Primate Models of Zika Virus Infection, Immunity, and Therapeutic Development.
J Infect Dis. 2017;216.
PubMed Abstract available

PRIYAMVADA L, Suthar MS, Ahmed R, Wrammert J, et al
Humoral Immune Responses Against Zika Virus Infection and the Importance of Preexisting Flavivirus Immunity.
J Infect Dis. 2017;216.
PubMed Abstract available

MORENS DM, Fauci AS
Pandemic Zika: A Formidable Challenge to Medicine and Public Health.
J Infect Dis. 2017;216.
PubMed

VOIGT EA, Haralambieva IH, Larrabee BL, Kennedy RB, et al
Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variations in Rubella Virus-Specific Cellular Immunity After Measles-Mumps-Rubella II Vaccination.
J Infect Dis. 2017 Dec 14. pii: 4743250. doi: 10.1093.
PubMed Abstract available

MADARAS-KELLY K, Remington R, Hruza H, Xu D, et al
The Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines in Preventing Post-Influenza Deaths.
J Infect Dis. 2017 Dec 9. pii: 4718125. doi: 10.1093.
PubMed

YOUNG B, Sadarangani S, Jiang L, Wilder-Smith A, et al
The Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis and Meta-regression of Test-Negative Design Case-control Studies.
J Infect Dis. 2017 Dec 6. pii: 4694421. doi: 10.1093.
PubMed Abstract available

OHFUJI S, Deguchi M, Tachibana D, Koyama M, et al
Protective effect of maternal influenza vaccination on influenza in their infants: a prospective cohort study.
J Infect Dis. 2017 Dec 5. pii: 4693945. doi: 10.1093.
PubMed Abstract available

BURN C, Ramsey N, Garforth SJ, Almo S, et al
An HSV-2 single-cycle candidate vaccine deleted in glycoprotein D, DeltagD-2, protects male mice from lethal skin challenge with clinical isolates of HSV-1 and HSV-2.
J Infect Dis. 2017 Dec 5. pii: 4693944. doi: 10.1093.
PubMed Abstract available

LIU WC, Lin CS, Yeh CC, Wu HY, et al
Effect of Influenza Vaccination Against Postoperative Pneumonia and Mortality for Geriatric Patients Receiving Major Surgery: A Nationwide Matched Study.
J Infect Dis. 2017 Dec 5. pii: 4690590. doi: 10.1093.
PubMed Abstract available

HAGAN JE, Takashima Y, Sarankhuu A, Dashpagma O, et al
Risk Factors for Measles Virus Infection Among Adults During a Large Outbreak in Postelimination Era in Mongolia, 2015.
J Infect Dis. 2017;216:1187-1195.
PubMed Abstract available

November 2017

MOODIE Z, Juraska M, Huang Y, Zhuang Y, et al
Neutralizing Antibody Correlates Analysis of Tetravalent Dengue Vaccine Efficacy Trials in Asia and Latin America.
J Infect Dis. 2017 Nov 29. pii: 4675250. doi: 10.1093.
PubMed Abstract available

SCHERER EM, Smith RA, Carter JJ, Wipf GC, et al
Analysis of memory B cell responses reveals suboptimal dosing schedule of a licensed vaccine.
J Infect Dis. 2017 Nov 24. pii: 4657105. doi: 10.1093.
PubMed Abstract available

HIRAMATSU H, Suzuki R, Nagatani A, Boda H, et al
Rotavirus vaccination can be performed without viral dissemination in the Neonatal Intensive Care Unit.
J Infect Dis. 2017 Nov 20. doi: 10.1093.
PubMed Abstract available

DREW DR, Sanders PR, Weiss G, Gilson PR, et al
Functional conservation of the AMA1 host-cell invasion ligand between P. falciparum and P. vivax: a novel platform to accelerate vaccine and drug development.
J Infect Dis. 2017 Nov 20. doi: 10.1093.
PubMed Abstract available

CHEN HL, Wen WH, Chang MH
Management of Pregnant Women and Children: Focusing on Preventing Mother-to-Infant Transmission.
J Infect Dis. 2017;216.
PubMed Abstract available

OLDFIELD NJ, Green LR, Parkhill J, Bayliss CD, et al
Limited impact of adolescent meningococcal ACWY vaccination on group W carriage in university students.
J Infect Dis. 2017 Nov 15. doi: 10.1093.
PubMed Abstract available

LEROUX-ROELS G, Cramer JP, Mendelman PM, Sherwood J, et al
Safety and immunogenicity of different formulations of norovirus vaccine candidate in healthy adults: a randomized, controlled, double-blind clinical trial.
J Infect Dis. 2017 Nov 13. doi: 10.1093.
PubMed Abstract available

WOESTENBERG PJ, King AJ, van Benthem BHB, Donken R, et al
Bivalent vaccine effectiveness against type-specific HPV positivity: evidence for cross-protection against oncogenic types among Dutch STI clinic visitors.
J Infect Dis. 2017 Nov 11. doi: 10.1093.
PubMed Abstract available

NOVAKOVIC D, Cheng ATL, Zurynski Y, Booy R, et al
A Prospective Study of the Incidence of Juvenile-Onset Recurrent Respiratory Papillomatosis After Implementation of a National HPV Vaccination Program.
J Infect Dis. 2017 Nov 9. doi: 10.1093.
PubMed Abstract available

DONOVAN B, Callander D
Juvenile-Onset Recurrent Respiratory Papillomatosis: The Benefits of Quadrivalent Human Papillomavirus Vaccination Continue to Accrue.
J Infect Dis. 2017 Nov 9. doi: 10.1093.
PubMed

SALEEM AF, Mach O, Yousafzai MT, Khan A, et al
Immunogenicity of Different Routine Poliovirus Vaccination Schedules: a Randomized Controlled Trial, Karachi, Pakistan.
J Infect Dis. 2017 Nov 6. doi: 10.1093.
PubMed Abstract available

VANDERVEN HA, Jegaskanda S, Wines BD, Hogarth PM, et al
Antibody-dependent cellular cytotoxicity (ADCC) responses to seasonal influenza vaccination in older adults.
J Infect Dis. 2017 Nov 2. doi: 10.1093.
PubMed Abstract available

LIN SM, Jang AY, Zhi Y, Gao S, et al
Immunization with a Latch Peptide Provides Serotype-Independent Protection against Group B Streptococcus Infection in Mice.
J Infect Dis. 2017 Nov 2. doi: 10.1093.
PubMed Abstract available

October 2017

SICRE DE FONTBRUNE F, Arnaud C, Cheminant M, Boulay A, et al
Immunogenicity and safety of yellow fever vaccine in allogeneic hematopoietic stem cell transplant recipients after withdrawal of immunosuppressive therapy.
J Infect Dis. 2017 Oct 26. doi: 10.1093.
PubMed Abstract available

SKOWRONSKI DM, Chambers C, De Serres G
Selection bias in the assessment of frailty and its role in influenza vaccine effectiveness evaluation among elderly adults.
J Infect Dis. 2017 Oct 13. doi: 10.1093.
PubMed

SKOWRONSKI DM, Chambers C, Sabaiduc S, De Serres G, et al
Beyond antigenic match: possible agent-host and immuno-epidemiological influences on influenza vaccine effectiveness during the 2015-16 season in Canada.
J Infect Dis. 2017 Oct 4. doi: 10.1093.
PubMed Abstract available

September 2017

BELONGIA E
Beyond Antigenic Match: Moving Toward Greater Understanding of Influenza Vaccine Effectiveness.
J Infect Dis. 2017 Sep 27. doi: 10.1093.
PubMed

OXMAN MN, Harbecke R, Koelle DM
Clinical Usage of the Candidate Adjuvanted HZ/su Zoster Vaccine: re-vaccination of recipients of live attenuated zoster vaccine and co-administration with a seasonal influenza vaccine.
J Infect Dis. 2017 Sep 26. doi: 10.1093.
PubMed

SCHWARZ TF, Aggarwal N, Moeckesch B, Schenkenberger I, et al
Immunogenicity and safety of an adjuvanted herpes zoster subunit vaccine co-administered with seasonal influenza vaccine in adults aged 50 years and older.
J Infect Dis. 2017 Sep 26. doi: 10.1093.
PubMed Abstract available

GRUPPING K, Campora L, Douha M, Heineman TC, et al
Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated with a Live-Attenuated Herpes Zoster Vaccine.
J Infect Dis. 2017 Sep 26. doi: 10.1093.
PubMed Abstract available

FALLOON J, Yu J, Esser MT, Villafana T, et al
An Adjuvanted, Postfusion F Protein-Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults.
J Infect Dis. 2017 Sep 23. doi: 10.1093.
PubMed Abstract available

NICHOLSON E, Piedra PA
Local Versus Global Enterovirus (EV) Surveillance: A Discussion For The Need for Active Surveillance To Guide EV A71 Vaccines.
J Infect Dis. 2017 Sep 23. doi: 10.1093.
PubMed

LANGLEY JM
Vaccine Prevention of Respiratory Syncytial Virus in Older Adults: The Work Continues.
J Infect Dis. 2017 Sep 23. doi: 10.1093.
PubMed

LEVINE MZ, Holiday C, Liu F, Jefferson S, et al
Cross-Reactive Antibody Responses to Novel H5Nx Influenza Viruses Following Homologous and Heterologous Prime-Boost Vaccination with a Prepandemic Stockpiled A(H5N1) Vaccine in Humans.
J Infect Dis. 2017;216.
PubMed Abstract available

JONES EN, Amoah S, Cao W, Sambhara S, et al
An Adjuvanted A(H5N1) Subvirion Vaccine Elicits Virus-Specific Antibody Response and Improves Protection Against Lethal Influenza Viral Challenge in Mouse Model of Protein Energy Malnutrition.
J Infect Dis. 2017;216.
PubMed Abstract available

PODDIGHE D
2-Dose Schedule of AS04-Adjuvanted Human Papillomavirus Types 16/18 Vaccine.
J Infect Dis. 2017;216:782-783.
PubMed

TAI CS, Wu JF, Chen HL, Ni YH, et al
The Impact of Hepatitis B Vaccine Failure on Long-term Natural Course of Chronic Hepatitis B Virus Infection in Hepatitis B e Antigen-Seropositive Children.
J Infect Dis. 2017;216:662-669.
PubMed Abstract available

TORRESI J, Richmond PC, Heron LG, Qiao M, et al
Replication and Excretion of the Live Attenuated Tetravalent Dengue Vaccine CYD-TDV in a Flavivirus-Naive Adult Population: Assessment of Vaccine Viremia and Virus Shedding.
J Infect Dis. 2017 Sep 14. doi: 10.1093.
PubMed Abstract available

DROLET M, Laprise JF, Brotherton JML, Donovan B, et al
The impact of human papillomavirus catch-up vaccination in Australia: Implications for introduction of multiple age cohort vaccination and post-vaccination data interpretation.
J Infect Dis. 2017 Sep 12. doi: 10.1093.
PubMed Abstract available

DUNKLE LM, Izikson R, Patriarca PA, Goldenthal KL, et al
Randomized Comparison of Immunogenicity and Safety of Quadrivalent Recombinant versus Inactivated Influenza Vaccine in Healthy Adults 18-49 Years of Age.
J Infect Dis. 2017 Sep 9. doi: 10.1093.
PubMed Abstract available

AKE JA, Schuetz A, Pegu P, Wieczorek L, et al
Safety and Immunogenicity of PENNVAX(R)-G DNA Prime Administered by Biojector(R) 2000 or CELLECTRA(R) Electroporation Device with Modified Vaccinia Ankara-CMDR Boost.
J Infect Dis. 2017 Sep 2. doi: 10.1093.
PubMed Abstract available

NING T, Wolfe A, Nie J, Huang W, et al
Naturally Occurring Single Amino Acid Substitution in the L1 Major Capsid Protein of Human Papillomavirus Type 16: Alteration of Susceptibility to Antibody-Mediated Neutralization.
J Infect Dis. 2017 Sep 2. doi: 10.1093.
PubMed Abstract available

OLIVER SE, Unger ER, Lewis R, McDaniel D, et al
Prevalence of Human Papillomavirus Among Females After Vaccine Introduction-National Health and Nutrition Examination Survey, United States, 2003-2014.
J Infect Dis. 2017;216:594-603.
PubMed Abstract available

August 2017

MCNAMARA LA, Thomas JD, MacNeil J, Chang HY, et al
Meningococcal Carriage Following a University Serogroup B Meningococcal Disease Outbreak and Vaccination Campaign with MenB-4C and MenB-FHbp - Oregon, 2015-2016.
J Infect Dis. 2017 Aug 26. doi: 10.1093.
PubMed Abstract available

LEHTINEN T, Soderlund-Strand A, Petaja T, Eriksson T, et al
Human papillomavirus (HPV) prevalence in adolescent males four years post HPV16/18 vaccination.
J Infect Dis. 2017 Aug 24. doi: 10.1093.
PubMed Abstract available

MODROF J, Tille B, Farcet MR, McVey J, et al
Measles Virus Neutralizing Antibodies in Intravenous Immunoglobulins:is an Increase by Re-Vaccination of Plasma Donors possible?
J Infect Dis. 2017 Aug 18. doi: 10.1093.
PubMed Abstract available

NEUZIL KM, Chen WH
Influenza Vaccines for Older Persons: Progress and Pitfalls.
J Infect Dis. 2017;216:397-398.
PubMed

ANDREW MK, Shinde V, Ye L, Hatchette T, et al
The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People.
J Infect Dis. 2017;216:405-414.
PubMed Abstract available

VAN BEEK J, Veenhoven RH, Bruin JP, van Boxtel RAJ, et al
Influenza-like Illness Incidence Is Not Reduced by Influenza Vaccination in a Cohort of Older Adults, Despite Effectively Reducing Laboratory-Confirmed Influenza Virus Infections.
J Infect Dis. 2017;216:415-424.
PubMed Abstract available

MCELHANEY JE, McNeil SA
Test-Negative Design: The Importance of Laboratory-Confirmed Illness in Estimating the Effectiveness of Influenza Vaccine in Older Adults.
J Infect Dis. 2017;216:399-401.
PubMed

LIBRATY DH
Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau.
J Infect Dis. 2017;216:502-503.
PubMed

July 2017

PATEL M, Cochi S
Addressing the Challenges and Opportunities of the Polio Endgame: Lessons for the Future.
J Infect Dis. 2017;216.
PubMed Abstract available

ZIPURSKY S, Vandelaer J, Brooks A, Dietz V, et al
Polio Endgame: Lessons Learned From the Immunization Systems Management Group.
J Infect Dis. 2017;216.
PubMed Abstract available

PEDREIRA C, Thrush E, Jauregui B
Systematization of the Introduction of IPV and Switch from tOPV to bOPV in the Americas.
J Infect Dis. 2017;216.
PubMed Abstract available

March 2017

PETRIE JG, Monto AS
Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness.
J Infect Dis. 2017;215:841-843.
PubMed

COHEN JI
Vaccination to Reduce Reactivation of Herpes Simplex Virus Type 2.
J Infect Dis. 2017;215:844-846.
PubMed

MONTO AS
Moving Toward Improved Influenza Vaccines.
J Infect Dis. 2017 Mar 2. doi: 10.1093.
PubMed

December 2016

HADLER JL
Christmas-New Year influenza lull: not too late for vaccination.
J Infect Dis. 2016 Dec 28. pii: jiw643. doi: 10.1093.
PubMed

FEDSON DS
Statins, Influenza Vaccination and Influenza.
J Infect Dis. 2016.
PubMed

May 2016

VIROJANAPIROM P, Lumlertdacha B, Wipattanakitchareon A, Hemachudha T, et al
T-705 as a potential therapeutic in rabies.
J Infect Dis. 2016.
PubMed

February 2016

MASCITELLI L, Goldstein MR
How regulatory T cells induction by statin drugs may impair influenza vaccine immunogenicity and effectiveness.
J Infect Dis. 2016.
PubMed

TITA AT, Andrews WW
Influenza Vaccination and Antiviral Therapy in Pregnant Women.
J Infect Dis. 2016.
PubMed

January 2016

VAN DAMME P
Long-term Protection After Hepatitis B Vaccine.
J Infect Dis. 2016.
PubMed

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: